Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain
- PMID: 31238111
- DOI: 10.1016/j.biocel.2019.06.006
Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain
Erratum in
-
Corrigendum to "Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain" [Int. J. Biochem. Cell Biol. 114 (September 2019) 105558].Int J Biochem Cell Biol. 2019 Sep;114:105577. doi: 10.1016/j.biocel.2019.105577. Epub 2019 Aug 5. Int J Biochem Cell Biol. 2019. PMID: 31391149
Abstract
The figure describes the location of UHRF1 (Ubiquitin-like with containing PHD and RING Finger domains 1) gene, mRNA and protein synthesis in the tumor cell and its structural domains with a focus on the docking of Naphthazarin on the SRA domain of UHRF1, resulting in reduction of tumor size.
Keywords: Cancer; SRA domain; UHRF1; Universal oncogene.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
